+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

CRISPR-Based Diagnostics Market Size, Share & Trends Analysis Report by Product (Enzymes, Kits & Reagents, Software & Libraries), Technology (Cas9, Cas12), Application, End-use, and Region with Growth Forecasts, 2025-2030

  • PDF Icon

    Report

  • 100 Pages
  • May 2025
  • Region: Global
  • Grand View Research
  • ID: 6098173
Description Jump to:
The CRISPR-Based Diagnostics Market was valued at USD 3.08 billion in 2024, and is projected to reach USD 7.55 billion by 2030, rising at a CAGR of 16.57%. Technological innovations have been pivotal in propelling the CRISPR diagnostics market forward. The development of novel Cas enzymes, such as Cas12 and Cas13, has enhanced the sensitivity and specificity of CRISPR-based diagnostic tests. These advancements have facilitated the creation of rapid, point-of-care (POC) diagnostic tools capable of detecting pathogens and genetic mutations with high accuracy. In August 2023, Indian biotech startup CrisprBits collaborated with Molbio Diagnostics to develop CRISPR-based POC tests. This partnership led to the creation of the PathCrisp platform, designed for rapid and precise disease detection, and has been instrumental in expanding the availability of CRISPR diagnostics in resource-limited settings. Such collaborations exemplify how technological advancements are translating into practical diagnostic solutions.

The surge in market size is attributed to factors such as increased healthcare spending, heightened demand for gene editing technologies, and a growing prevalence of chronic and genetic diseases. For instance, the World Health Organization reported in 2024 that tuberculosis (TB) remained the second most common infectious disease worldwide, with an estimated 10.8 million people diagnosed in 2023 Such statistics underscore the pressing need for advanced diagnostic tools such as CRISPR-based tests.

The increasing incidence of genetic disorders and infectious diseases globally has amplified the demand for advanced diagnostic tools. According to the International Agency for Research on Cancer, the number of new cancer cases worldwide is expected to rise from 21.3 million in 2025 to 35.3 million by 2050. Similarly, research published in The Lancet in August 2024 highlighted a higher-than-expected prevalence of cystic fibrosis in non-European populations, particularly in the Indian subcontinent. These trends underscore the necessity for precise and rapid diagnostic methods, such as CRISPR-based tests, which can facilitate early detection and treatment of various diseases. The ability of CRISPR diagnostics to accurately identify specific genetic sequences makes them invaluable in managing the growing burden of genetic and infectious diseases.

Geographically, the CRISPR diagnostics market exhibits varying growth patterns. Asia-Pacific currently holds the largest market share, driven by a high prevalence of infectious diseases and increasing investments in healthcare infrastructure. Conversely, North America is projected to be the fastest-growing region, attributed to substantial research and development investments and early adoption of advanced diagnostic technologies. For instance, in September 2023, Sherlock Biosciences received additional funding from the Bill & Melinda Gates Foundation to enhance the development of rapid, instrument-free molecular diagnostics leveraging CRISPR technology for Human Papillomavirus (HPV) detection . Such initiatives reflect the regional efforts to harness CRISPR technology in addressing public health challenges.

CRISPR-based Diagnostics Market Report Highlights

  • In 2024, kits and reagents led the market with a largest revenue share, driven by the widespread deployment of CRISPR-based detection systems in both clinical and research settings. The increasing global demand for point-of-care diagnostics, particularly for infectious and genetic diseases, has amplified the need for ready-to-use diagnostic kits and high-quality reagents.
  • The Cas9 segment secured the dominant market share in 2024, due to its foundational role in the development of CRISPR technologies. As the first and most widely studied CRISPR-associated protein, Cas9 has been instrumental in enabling precise DNA targeting and cleavage, making it a preferred tool for genetic diagnostics
  • The infectious disease diagnostics held the largest market share in 2024, driven by the urgent global need for rapid, accurate, and scalable testing solutions. CRISPR technologies, particularly those leveraging Cas12 and Cas13, enable highly sensitive detection of viral and bacterial pathogens by identifying nucleic acid sequences with precision.
  • Pharmaceutical and biotechnology companies held the dominant market share in 2024 and is expected to be the fastest-growing segment over the forecast period. driven by the rising prevalence of infectious diseases such as HIV, hepatitis, tuberculosis, and respiratory infections, which require accurate and timely diagnosis.
  • North America dominated the global market with the largest revenue share in 2024, driven by a high burden of chronic and infectious diseases, a growing focus on personalized medicine, substantial R&D spending, and advances in point-of-care testing.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Why Should You Buy This Report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
1.3.1. Information Procurement
1.3.2. Information or Data Analysis
1.3.3. Market Formulation & Data Visualization
1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
1.4.1. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. CRISPR-Based Diagnostics Market Variables, Trends, & Scope
3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
3.3.1. Market Drivers Analysis
3.3.2. Market Restraints Analysis
3.4. CRISPR-Based Diagnostics Market Analysis Tools
3.4.1. Porter’s Analysis
3.4.1.1. Bargaining power of the suppliers
3.4.1.2. Bargaining power of the buyers
3.4.1.3. Threats of substitution
3.4.1.4. Threats from new entrants
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Economic and Social landscape
3.4.2.3. Technological landscape
3.4.2.4. Environmental landscape
3.4.2.5. Legal landscape
Chapter 4. CRISPR-Based Diagnostics Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. CRISPR-Based Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Million)
4.3. Enzymes
4.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.4. Kits and Reagents
4.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
4.5. Software and Libraries
4.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 5. CRISPR-Based Diagnostics Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. CRISPR-Based Diagnostics Market: Technology Movement Analysis, USD Million, 2024 & 2030
5.3. Cas9
5.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.4. Cas12
5.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
5.5. Others
5.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 6. CRISPR-Based Diagnostics Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. CRISPR-Based Diagnostics Market: Application Movement Analysis, USD Million, 2024 & 2030
6.3. Infectious Disease Diagnostics
6.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.4. Genetic Disorder Diagnostics
6.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.5. Cancer Diagnostics
6.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
6.6. Others
6.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 7. CRISPR-Based Diagnostics Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. CRISPR-Based Diagnostics Market: End Use Movement Analysis, USD Million, 2024 & 2030
7.3. Hospitals and Clinics Diagnostic
7.3.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.4. Laboratories
7.4.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.5. Pharmaceutical and Biotechnology Companies
7.5.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
7.6. Others
7.6.1. Market Revenue Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 8. CRISPR-Based Diagnostics Market: Regional Estimates & Trend Analysis
8.1. CRISPR-Based Diagnostics Market Share, By Region, 2024 & 2030 ( USD Million)
8.2. North America
8.2.1. North America CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.2. U.S.
8.2.2.1. U.S. CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.3. Canada
8.2.3.1. Canada CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Mexico CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3. Europe
8.3.1. Europe CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.2. UK
8.3.2.1. UK CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.3. Germany
8.3.3.1. Germany CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.4. France
8.3.4.1. France CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.5. Italy
8.3.5.1. Italy CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.6. Spain
8.3.6.1. Spain CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.7. Denmark
8.3.7.1. Denmark CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.8. Sweden
8.3.8.1. Sweden CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.3.9. Norway
8.3.9.1. Norway CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.2. Japan
8.4.2.1. Japan CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.3. China
8.4.3.1. China CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.4. India
8.4.4.1. India CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.5. Australia
8.4.5.1. Australia CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.6. South Korea
8.4.6.1. South Korea CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.4.7. Thailand
8.4.7.1. Thailand CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5. Latin America
8.5.1. Latin America CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Brazil CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Argentina CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6. Middle East and Africa
8.6.1. Middle East and Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.2. South Africa
8.6.2.1. South Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.3. Saudi Arabia
8.6.3.1. South Africa CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.4. UAE
8.6.4.1. UAE CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Kuwait CRISPR-Based Diagnostics Market Estimates and Forecasts, 2018-2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis by Key Market Participants
9.2. Company Categorization
9.3. Company Heat Map Analysis
9.4. Company Profiles
9.4.1. Thermo Fisher Scientific Inc.
9.4.1.1. Participant’s Overview
9.4.1.2. Financial Performance
9.4.1.3. Product Benchmarking
9.4.1.4. Recent Developments/ Strategic Initiatives
9.4.2. Integrated DNA Technologies, Inc.
9.4.2.1. Participant’s Overview
9.4.2.2. Financial Performance
9.4.2.3. Product Benchmarking
9.4.2.4. Recent Developments/ Strategic Initiatives
9.4.3. Molbio Diagnostics
9.4.3.1. Participant’s Overview
9.4.3.2. Financial Performance
9.4.3.3. Product Benchmarking
9.4.3.4. Recent Developments/ Strategic Initiatives
9.4.4. Horizon Discovery
9.4.4.1. Participant’s Overview
9.4.4.2. Financial Performance
9.4.4.3. Product Benchmarking
9.4.4.4. Recent Developments/ Strategic Initiatives
9.4.5. Synthego Corporation
9.4.5.1. Participant’s Overview
9.4.5.2. Financial Performance
9.4.5.3. Product Benchmarking
9.4.5.4. Recent Developments/ Strategic Initiatives
9.4.6. Mammoth Biosciences
9.4.6.1. Participant’s Overview
9.4.6.2. Financial Performance
9.4.6.3. Product Benchmarking
9.4.6.4. Recent Developments/ Strategic Initiatives
9.4.7. Sherlock Biosciences
9.4.7.1. Participant’s Overview
9.4.7.2. Financial Performance
9.4.7.3. Product Benchmarking
9.4.7.4. Recent Developments/ Strategic Initiatives
9.4.8. Caribou Biosciences
9.4.8.1. Participant’s Overview
9.4.8.2. Financial Performance
9.4.8.3. Product Benchmarking
9.4.8.4. Recent Developments/ Strategic Initiatives
9.4.9. CrisprBits
9.4.9.1. Participant’s Overview
9.4.9.2. Financial Performance
9.4.9.3. Product Benchmarking
9.4.9.4. Recent Developments/ Strategic Initiatives
9.4.10. ToolGen Inc.
9.4.10.1. Participant’s Overview
9.4.10.2. Financial Performance
9.4.10.3. Product Benchmarking
9.4.10.4. Recent Developments/ Strategic Initiatives
List of Tables
Table 1 List of abbreviation
Table 2 Global CRISPR-based diagnostics market, by region, 2018-2030 (USD Million)
Table 3 Global CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 4 Global CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 5 Global CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 6 Global CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 7 North America CRISPR-based diagnostics market, by country, 2018-2030 (USD Million)
Table 8 North America CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 9 North America CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 10 North America CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 11 North America CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 12 U.S. CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 13 U.S. CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 14 U.S. CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 15 U.S. CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 16 Canada CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 17 Canada CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 18 Canada CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 19 Canada CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 20 Mexico CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 21 Mexico CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 22 Mexico CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 23 Mexico CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 24 Europe CRISPR-based diagnostics market, by country, 2018-2030 (USD Million)
Table 25 Europe CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 26 Europe CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 27 Europe CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 28 Europe CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 29 UK CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 30 UK CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 31 UK CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 32 UK CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 33 Germany CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 34 Germany CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 35 Germany CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 36 Germany CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 37 France CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 38 France CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 39 France CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 40 France CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 41 Italy CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 42 Italy CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 43 Italy CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 44 Italy CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 45 Spain CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 46 Spain CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 47 Spain CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 48 Spain CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 49 Denmark CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 50 Denmark CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 51 Denmark CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 52 Denmark CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 53 Sweden CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 54 Sweden CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 55 Sweden CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 56 Sweden CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 57 Norway CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 58 Norway CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 59 Norway CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 60 Norway CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 61 Asia Pacific CRISPR-based diagnostics market, by country, 2018-2030 (USD Million)
Table 62 Asia Pacific CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 63 Asia Pacific CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 64 Asia Pacific CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 65 Asia Pacific CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 66 Japan CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 67 Japan CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 68 Japan CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 69 Japan CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 70 China CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 71 China CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 72 China CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 73 China CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 74 India CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 75 India CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 76 India CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 77 India CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 78 Australia CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 79 Australia CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 80 Australia CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 81 Australia CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 82 South Korea CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 83 South Korea CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 84 South Korea CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 85 South Korea CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 86 Thailand CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 87 Thailand CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 88 Thailand CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 89 Thailand CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 90 Latin America CRISPR-based diagnostics market, by country, 2018-2030 (USD Million)
Table 91 Latin America CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 92 Latin America CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 93 Latin America CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 94 Latin America CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 95 Brazil CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 96 Brazil CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 97 Brazil CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 98 Brazil CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 99 Argentina CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 100 Argentina CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 101 Argentina CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 102 Argentina CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 103 MEA CRISPR-based diagnostics market, by country, 2018-2030 (USD Million)
Table 104 MEA CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 105 MEA CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 106 MEA CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 107 MEA CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 108 South Africa CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 109 South Africa CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 110 South Africa CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 111 South Africa CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 112 Saudi Arabia CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 113 Saudi Arabia CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 114 Saudi Arabia CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 115 Saudi Arabia CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 116 UAE CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 117 UAE CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 118 UAE CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 119 UAE CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
Table 120 Kuwait CRISPR-based diagnostics market, by product, 2018-2030 (USD Million)
Table 121 Kuwait CRISPR-based diagnostics market, by technology, 2018-2030 (USD Million)
Table 122 Kuwait CRISPR-based diagnostics market, by application, 2018-2030 (USD Million)
Table 123 Kuwait CRISPR-based diagnostics market, by end-use, 2018-2030 (USD Million)
List of Figures
Figure 1 CRISPR-based diagnostics market segmentation
Figure 2 Data analysis models
Figure 3 Market formulation and validation
Figure 4 Data validating & publishing
Figure 5 Market research process
Figure 6 Information procurement
Figure 7 Primary research
Figure 8 Value-chain-based sizing & forecasting
Figure 9 QFD modelling for market share assessment
Figure 10 Market formulation & validation
Figure 11 Commodity flow analysis
Figure 12 Market outlook
Figure 13 Segment snapshot-1
Figure 14 Segment snapshot-2
Figure 15 Competitive landscape snapshot
Figure 16 Market trends & outlook
Figure 17 Porter’s five force analysis
Figure 18 PESTEL analysis
Figure 19 CRISPR-based diagnostics market: Product outlook key takeaways
Figure 20 CRISPR-based diagnostics market: Product movement analysis
Figure 21 Transfemoral market estimates and forecasts, 2018-2030 (USD Million)
Figure 22 Enzymes market estimates and forecasts, 2018-2030 (USD Million)
Figure 23 Kits and Reagents market estimates and forecasts, 2018-2030 (USD Million)
Figure 24 Software and libraries market estimates and forecasts, 2018-2030 (USD Million)
Figure 25 CRISPR-based diagnostics market: Technology outlook key takeaways
Figure 26 CRISPR-based diagnostics market: Technology movement analysis
Figure 27 Cas9 market estimates and forecasts, 2018-2030 (USD Million)
Figure 28 Cas12 market estimates and forecasts, 2018-2030 (USD Million)
Figure 29 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 30 CRISPR-based diagnostics market: Application outlook key takeaways
Figure 31 CRISPR-based diagnostics market: Application movement analysis
Figure 32 Infectious disease diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 33 Genetic disorder diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 34 Cancer diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 35 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 36 CRISPR-based diagnostics market: End-use outlook key takeaways
Figure 37 CRISPR-based diagnostics market: End-use movement analysis
Figure 38 Hospitals and clinics diagnostic market estimates and forecasts, 2018-2030 (USD Million)
Figure 39 Laboratories market estimates and forecasts, 2018-2030 (USD Million)
Figure 40 Pharmaceutical and biotechnology companies market estimates and forecasts, 2018-2030 (USD Million)
Figure 41 Others market estimates and forecasts, 2018-2030 (USD Million)
Figure 42 Regional marketplace outlook, 2024 & 2030 (USD Million)
Figure 43 Regional marketplace: Key takeaways
Figure 44 North America CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 45 Key country dynamics
Figure 46 U.S. CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 47 Key country dynamics
Figure 48 Canada CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 49 Key country dynamics
Figure 50 Mexico CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 51 Europe CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 52 Key country dynamics
Figure 53 UK CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 54 Key country dynamics
Figure 55 Germany CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 56 Key country dynamics
Figure 57 France CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 58 Key country dynamics
Figure 59 Spain CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 60 Key country dynamics
Figure 61 Italy CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 62 Key country dynamics
Figure 63 Denmark CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 64 Key country dynamics
Figure 65 Sweden CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 66 Key country dynamics
Figure 67 Norway CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 68 Asia Pacific CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 69 Key country dynamics
Figure 70 Japan CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 71 Key country dynamics
Figure 72 China CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 73 Key country dynamics
Figure 74 India CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 75 Key country dynamics
Figure 76 Australia CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 77 Key country dynamics
Figure 78 South Korea CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 79 Key country dynamics
Figure 80 Thailand CRISPR-based diagnostics market estimates and forecasts, 2018-2030 (USD Million)
Figure 81 Key country dynamics
Figure 82 Market participant categorization
Figure 83 CRISPR-based diagnostics market position analysis, 2024
Figure 84 Strategic framework

Companies Mentioned

The major companies featured in this CRISPR-Based Diagnostics market report include:
  • Thermo Fisher Scientific Inc.
  • Integrated DNA Technologies, Inc.
  • Molbio Diagnostics
  • Horizon Discovery
  • Synthego Corporation
  • Mammoth Biosciences
  • Sherlock Biosciences
  • Caribou Biosciences
  • CrisprBits
  • ToolGen Inc.

Table Information

Report AttributeDetails
No. of Pages100
PublishedMay 2025
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 3.08 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.55 Billion
Compound Annual Growth Rate16.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

CRISPR & Cas Genes Market by Application, End User, Cas Type, Delivery Method, Technology - Global Forecast to 2030 - Product Image

CRISPR & Cas Genes Market by Application, End User, Cas Type, Delivery Method, Technology - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030 - Product Image

CRISPR-based Gene Editing Market Size, Share and Trends Analysis Report by Product & Service (CRISPR Kits & Reagents), Application (Biomedical, Agricultural), End-use, and Region 2024-2030

  • Report
  • 120 Pages
  • Global
From
CRISPR Technology Market by Offering, Delivery Method, Application, End-User - Global Forecast to 2030 - Product Image

CRISPR Technology Market by Offering, Delivery Method, Application, End-User - Global Forecast to 2030

  • Report
  • 180 Pages
  • Global
From
Genome Engineering Market by Technology, Product, Application, End User - Global Forecast to 2030 - Product Image

Genome Engineering Market by Technology, Product, Application, End User - Global Forecast to 2030

  • Report
  • 187 Pages
  • Global
From
CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

CRISPR And Cas Genes Market Size, Share & Trends Analysis Report By Product & Service (Kits & Reagents, Cell Line Engineering), By Application (Biomedical, Agricultural), By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.